Can't see anything new in the presentation that hasn't been made known previously, it was a timely release given the conference presentation is 8 days away and a reminder of the significance of positive results. The results have been embargoed for a month but the conclusion is apparent, negative results would not have been accepted for presentation nor would both companies be presenting jointly and most importantly the Janssen study was further extended. If the investor presentation has a confirmatory tone then it's because the results are known. The only reason for the embargo was to make it a big event announcement for its target audience.
PIQ has jumped most of the hurdles it's just a matter of some further regulatory approvals for a full global rollout and this is where Janssen can assist in expediting submissions and promote test use. The uptake will be enhanced from Janssen promoting the use of the test in conjunction with its drug and this was the inference in the presentation.
It will be interesting to see what comes from the Trading Halt but can't see it being material. It's the media promotion and announcements after the conference that's going to be of significance.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)